EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists

W. J. Fokkens(Amsterdam UMC Location University of Amsterdam), Valerie J. Lund(Royal National Throat Nose and Ear Hospital), J Mullol(Biomedical Research Institute), Claus Bachert(Ghent University Hospital), Isam Alobid(Biomedical Research Institute), Fuad M. Baroody(University of Chicago), Noah Cohen(California University of Pennsylvania), Anders Cervin, Richard Douglas(Auckland City Hospital), Philippe Gevaert(Ghent University Hospital), C. Georgalas(University of Amsterdam), H. Goossens(University of Antwerp), Richard J. Harvey(UNSW Sydney), Peter W. Hellings(KU Leuven), Claire Hopkins(St Thomas' Hospital), Nick S. Jones(University of Nottingham), Guy Joos(Ghent University Hospital), Livije Kalogjera(University of Zagreb), Benjamin Kern(Northwestern University), M. L. Kowalski(Medical University of Lodz), David Price(University of Aberdeen), Herbert Riechelmann(Innsbruck Medical University), Rodney J. Schlosser(Medical University of South Carolina), Brent A. Senior(Medical University of South Carolina), Mike Thomas(University of Southampton), Е. Тоскала(Children's Hospital of Philadelphia), Richard Louis Voegels(Universidade de São Paulo), D.Y. Wang(National University of Singapore), Peter‐John Wormald(Flinders University)
Rhinology Journal
March 1, 2012
Cited by 2,403

Abstract

The European Position Paper on Rhinosinusitis and Nasal Polyps 2012 is the update of similar evidence based position papers published in 2005 and 2007. The document contains chapters on definitions and classification, we now also proposed definitions for difficult to treat rhinosinusitis, control of disease and better definitions for rhinosinusitis in children. More emphasis is placed on the diagnosis and treatment of acute rhinosinusitis. Throughout the document the terms chronic rhinosinusitis without nasal polyps (CRSsNP) and chronic rhinosinusitis with nasal polyps (CRSwNP) are used to further point out differences in pathophysiology and treatment of these two entities. There are extensive chapters on epidemiology and predisposing factors, inflammatory mechanisms, (differential) diagnosis of facial pain, genetics, cystic fibrosis, aspirin exacerbated respiratory disease, immunodeficiencies, allergic fungal rhinosinusitis and the relationship between upper and lower airways. The chapters on paediatric acute and chronic rhinosinusitis are totally rewritten. Last but not least all available evidence for management of acute rhinosinusitis and chronic rhinosinusitis with or without nasal polyps in adults and children is analyzed and presented and management schemes based on the evidence are proposed. This executive summary for otorhinolaryngologists focuses on the most important changes and issues for otorhinolaryngologists. The full document can be downloaded for free on the website of this journal: http://www.rhinologyjournal.com.


Related Papers

No related papers found

Powered by citation graph analysis